-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NJdkHQ3k4CsWshX+krRIttTTndXun6/cjcom2uJNxlm383A1Ndk95Mm+GHR6MSkC kKLSrGc68dYZdf+sQCVhpg== 0001192482-10-000217.txt : 20100810 0001192482-10-000217.hdr.sgml : 20100810 20100810113529 ACCESSION NUMBER: 0001192482-10-000217 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100810 DATE AS OF CHANGE: 20100810 EFFECTIVENESS DATE: 20100810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TETRALOGIC PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001361248 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-146152 FILM NUMBER: 101004035 BUSINESS ADDRESS: STREET 1: 343 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-889-9900 MAIL ADDRESS: STREET 1: 343 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 D 1 primary_doc.xml X0704 D LIVE 0001361248 TETRALOGIC PHARMACEUTICALS CORP 343 PHOENIXVILLE PIKE MALVERN PA PENNSYLVANIA 19355 610-889-9900 DELAWARE None None Corporation true John M. Gill c/o TetraLogic Pharmaceuticals Corp. 343 Phoenixville Pike Malvern PA PENNSYLVANIA 19355 Executive Officer Director Mark A. McKinlay c/o TetraLogic Pharmaceuticals Corp. 343 Phoenixville Pike Malvern PA PENNSYLVANIA 19355 Executive Officer Harold Werner c/o HealthCare Ventures VII, L.P. 44 Nassau Street Princeton NJ NEW JERSEY 08542 Director Brenda Gavin c/o Quaker BioVentures Cira Center, 2929 Arch Street, Suite 325 Philadelphia PA PENNSYLVANIA 19104 Director Paul Schmitt c/o Novitas Capital III, L.P. 1200 Liberty Ridge Drive, Suite 310 Wayne PA PENNSYLVANIA 19087 Director Andrew Pecora c/o Pecora & Company, LLC 424 Hidden Valley Court Wyckoff NJ NEW JERSEY 07481 Director James Woody c/o Latterell Venture Partners 1 Embarcadero Center, Suite 4050 San Francisco CA CALIFORNIA 94111 Director Douglas Reed c/o Hatteras Venture Partners 280 S. Mangum Street, Suite 350 Durham NC NORTH CAROLINA 27701 Director Michael Steinmetz c/o Clarus Ventures, LLC 101 Main Street, Suite 1210 Cambridge MA MASSACHUSETTS 02142 Director Helga Kautsky c/o TetraLogic Pharmaceuticals Corp. 343 Phoenixville Pike Malvern PA PENNSYLVANIA 19355 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2010-07-26 false true false 0 32000000 12496000 19504000 false 10 0 0 0 false TETRALOGIC PHARMACEUTICALS CORP /s/ John M. Gill John M. Gill President & CEO 2010-08-10 -----END PRIVACY-ENHANCED MESSAGE-----